Peer Review History: Community Insights Regarding COVID-19 Vaccine Uptake Intention versus Hesitancy

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.

(2) Dr. Farzaneh Mohamadpour, University of Sistan and Baluchestan, Iran.

(3) Dr. Alyautdin Renad N, Professor and Head, Scientific Centre for Expert Evaluation of Medicinal Products, Moscow, Russia.

Reviewers:

(1) Zehua  Feng, Guangdong University of Finance & Economics, China.

(2) Nirmal  Kumar  Ganguly, Apollo Hospitals Educational Research Foundation, India.

(3) José López Castro, Hospital Público De Monforte – SERGAS, Spain.

(4) Hasta Handayani Idrus, Universitas Muslim Indonesia, Indonesian.

(5) Shaniko Kaleci, University of Modena and Reggio Emilia, Italy.

Additional Reviewers:

(1) Stefania Neiva Lavorato, Universidade Federal do Oeste Da Bahia, Brazil.

(2) Ashim Kumar Saikia, Assam Agricultural University Khanapara, India.

(3) Jesús G. Rodríguez Diego, Universidad Autónoma Metropolitana, México.

(4) Hean Teik Ong, HT Ong Heart Clinic, Malaysia.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Zehua  Feng, China) | File 1 | NA


Stage 2 | Peer review report_2 (Nirmal  Kumar  Ganguly, India) | File 1 | NA


Stage 2 | Peer review report_3 (José López Castro, Spain) | File 1 | NA


Stage 2 | Peer review report_4 (Hasta Handayani Idrus, Indonesia) | File 1 | NA


Stage 2 | Peer review report_5 (Shaniko Kaleci, Italy) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Stage 3 | Comment_Editor_3_v1 | File 1 | NA